Arpit Deepakkumar Shah

Arpit Deepakkumar Shah

Active Director Managing Director DIN 07214641
DIN 07214641 First appointment Sep 2015 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Past companies 1 historical roles
Total affiliations 7 Since Sep 2015
Shareholding value •••• Premium profile

About Arpit Deepakkumar Shah

Data last updated:

Arpit Deepakkumar Shah is a Managing Director at Remus Pharmaceuticals Limited (since 2015), Director at Senores Pharmaceuticals Limited (since 2023) and Director at Ratnatris Pharmaceuticals Private Limited (since 2021), and holds 3 more current directorships. The companies operate in Trading, Pharma and Real Estate and Construction. The 5 current companies with reported revenue have a combined latest revenue of ₹1,185 Cr; the largest is Remus Pharmaceuticals Limited at ₹625 Cr (FY 2025). Earlier, Arpit Deepakkumar Shah was a Designated Partner at Sumer Enterprises Llp (from 2018).

DIN 07214641
Primary Designation Managing Director
Industry Trading
First Appointment 21 Sep 2015
Oldest Company Age 20 yrs
Largest company Remus Pharmaceuticals Limited · ₹625 Cr (FY 2025)
Combined revenue ₹1,185 Cr across 5 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Remus Pharmaceuticals Limited L24232GJ2015PLC084536
Managing Director21 Sep 20152015₹625 Cr (FY 2025)Active
Senores Pharmaceuticals Limited L24290GJ2017PLC100263
Director10 Nov 20232017₹418 Cr (FY 2025)Active
Director15 Jan 20212005₹142 Cr (FY 2025)Active
Partner27 Jul 20232022₹2.1 Lakh (FY 2026)Active
Partner28 Jan 20212016₹85,669 (FY 2026)Active
Relius Lifesciences Private Limited U24299GJ2016PTC094454
Director21 Nov 20162016Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner13 Aug 20182018Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Arpit Deepakkumar Shah

NameDINCompanyDesignation
Anar Swapnil Shah06895297Remus Pharmaceuticals Limited , Relius Lifesciences Private LimitedDirector
Ashutosh Naginbhai Valani00559688Remus Pharmaceuticals LimitedAdditional Director
Balwant Purohit09806032Remus Pharmaceuticals LimitedDirector
Bhavik Rashmikant ShahRemus Pharmaceuticals LimitedCfo
Deval Bakulkumar PatelRemus Pharmaceuticals LimitedCompany Secretary
Roma Vinodbhai Shah07214632Remus Pharmaceuticals Limited , Relius Lifesciences Private LimitedWhole-Time Director
Sanjana Sanjeev Shah09811689Remus Pharmaceuticals LimitedDirector
Swapnil Jatinbhai Shah05259821Remus Pharmaceuticals Limited , Senores Pharmaceuticals Limited and 2 moreDirector
Vishrut Chandramauli Pathak03278445Remus Pharmaceuticals LimitedDirector
Ashokkumar Vijaysinh Barot01192300Senores Pharmaceuticals LimitedDirector
Chetan Bipinchandra Shah10381971Senores Pharmaceuticals Limited , Ratnatris Pharmaceuticals Private LimitedWhole-Time Director
Deval Rajnikant Shah00332722Senores Pharmaceuticals LimitedWhole-Time Director
Deval Rajnikant ShahSenores Pharmaceuticals LimitedCfo
Hemanshu Nitinchandra Pandya10383995Senores Pharmaceuticals LimitedDirector
Jitendra Babulal Sanghvi00271995Senores Pharmaceuticals Limited , Ratnatris Pharmaceuticals Private LimitedDirector
Kalpit Rajesh Gandhi02843308Senores Pharmaceuticals Limited , Ratnatris Pharmaceuticals Private LimitedDirector
Manjula Devi Shroff00297159Senores Pharmaceuticals LimitedDirector
Naresh Bansilal Shah10384306Senores Pharmaceuticals LimitedDirector
Sanjay Shaileshbhai Majmudar00091305Senores Pharmaceuticals LimitedDirector
Udayan Dileep Choksi02222020Senores Pharmaceuticals Limited , Ratnatris Pharmaceuticals Private LimitedDirector
Aniruddh Darshanbhai Jhaveri08076497Newmark Properties Llp , Calypso Hospitality LlpDesignated Partner
Gaurav Hasmukh Gadhecha03473116Newmark Properties LlpDesignated Partner
Shaan Anand Zaveri00114826Calypso Hospitality LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Calypso Hospitality Llp
Ratnatris Pharmaceuticals Private Limited
Relius Lifesciences Private Limited
Sumer Enterprises Llp
Premium access

Shareholding and investment profile for Arpit Deepakkumar Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arpit Deepakkumar Shah

Arpit Deepakkumar Shah currently holds 6 directorships: Remus Pharmaceuticals Limited (Managing Director, since 21 Sep 2015, revenue ₹625 Cr (FY 2025)); Senores Pharmaceuticals Limited (Director, since 10 Nov 2023, revenue ₹418 Cr (FY 2025)); Ratnatris Pharmaceuticals Private Limited (Director, since 15 Jan 2021, revenue ₹142 Cr (FY 2025)); Newmark Properties Llp (Partner, since 27 Jul 2023, revenue ₹2.1 Lakh (FY 2026)); Calypso Hospitality Llp (Partner, since 28 Jan 2021, revenue ₹85,669 (FY 2026)); and 1 more.

Arpit Deepakkumar Shah was first appointed on 21 Sep 2015 as Managing Director at Remus Pharmaceuticals Limited. The most recent appointment on record is 10 Nov 2023 at Senores Pharmaceuticals Limited.

The 5 current companies of Arpit Deepakkumar Shah that report revenue have a combined latest revenue of ₹1,185 Cr: Remus Pharmaceuticals Limited ₹625 Cr (FY 2025); Senores Pharmaceuticals Limited ₹418 Cr (FY 2025); Ratnatris Pharmaceuticals Private Limited ₹142 Cr (FY 2025); Newmark Properties Llp ₹2.1 Lakh (FY 2026); Calypso Hospitality Llp ₹85,669 (FY 2026).

Arpit Deepakkumar Shah held 1 earlier board appointment: Sumer Enterprises Llp (Designated Partner, from 13 Aug 2018).

The current boards of Arpit Deepakkumar Shah's companies include Anar Swapnil Shah (Remus Pharmaceuticals Limited), Ashutosh Naginbhai Valani (Remus Pharmaceuticals Limited), Balwant Purohit (Remus Pharmaceuticals Limited), Bhavik Rashmikant Shah (Remus Pharmaceuticals Limited), Deval Bakulkumar Patel (Remus Pharmaceuticals Limited), Roma Vinodbhai Shah (Remus Pharmaceuticals Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available